Antibodies
Ended Purchase Order Awarded Last action
- Contract number
- 75N91025P00106
- Awardee
-
Cosmo Bio USA Inc. UEI VTSXMSTS9C69
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $14,682
Award facts
- Contract value 100% obligated
- $14,682.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 2 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Carlsbad, CA 92010, USA
Award details come from SAM.gov/FPDS.
About this award
This is a firm fixed-price purchase order awarded by the National Cancer Institute (NCI), a civilian agency of the U.S. government, to Cosmo Bio USA Inc. for the delivery of antibodies. The contract has a ceiling value of $14,682.40 and a completion date of February 25, 2025. The contract is not set aside for any specific business type. Cosmo Bio USA Inc. is a foreign-owned, for-profit organization.
Quick answers
Who was awarded contract 75N91025P00106?
75N91025P00106 was awarded to Cosmo Bio USA Inc. by National Cancer Institute (National Institutes of Health) on December 26, 2024.
How much is contract 75N91025P00106 worth?
The government has obligated $14,682 on 75N91025P00106.
Was contract 75N91025P00106 competed?
The extent of competition for 75N91025P00106 was competed under sap. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award